694 related articles for article (PubMed ID: 29434642)
1. The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.
Motta BM; Pramstaller PP; Hicks AA; Rossini A
Stem Cells Int; 2017; 2017():8960236. PubMed ID: 29434642
[TBL] [Abstract][Full Text] [Related]
2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-mediated genome editing and human diseases.
Cai L; Fisher AL; Huang H; Xie Z
Genes Dis; 2016 Dec; 3(4):244-251. PubMed ID: 30258895
[TBL] [Abstract][Full Text] [Related]
4. Genome editing in cardiovascular diseases.
Strong A; Musunuru K
Nat Rev Cardiol; 2017 Jan; 14(1):11-20. PubMed ID: 27609628
[TBL] [Abstract][Full Text] [Related]
5. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
[TBL] [Abstract][Full Text] [Related]
6. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 technology: applications and human disease modelling.
Torres-Ruiz R; Rodriguez-Perales S
Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic genome editing in cardiovascular diseases.
Nishiga M; Qi LS; Wu JC
Adv Drug Deliv Rev; 2021 Jan; 168():147-157. PubMed ID: 32092381
[TBL] [Abstract][Full Text] [Related]
10. [The application of CRISPR/Cas9 genome editing technology in cancer research].
Wang DY; Ma N; Hui Y; Gao X
Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
[TBL] [Abstract][Full Text] [Related]
11. Gene Editing in Clinical Practice: Where are We?
Mittal RD
Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
13. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
[TBL] [Abstract][Full Text] [Related]
15. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-Based Genome Editing in Plants.
Zhang Y; Ma X; Xie X; Liu YG
Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
19. Progress in the application of CRISPR: From gene to base editing.
Wu W; Yang Y; Lei H
Med Res Rev; 2019 Mar; 39(2):665-683. PubMed ID: 30171624
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro disease modeling with CRISPR/Cas9.
Kato T; Takada S
Brief Funct Genomics; 2017 Jan; 16(1):13-24. PubMed ID: 27497066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]